糖原合酶激酶 3 (GSK-3) 是一种多功能丝氨酸/苏氨酸激酶,由两种亚型组成,即 α 和 β。它是受体酪氨酸激酶、细胞因子和 Wnt 信号通路的高度保守负调节剂。这些通路的刺激会抑制 GSK-3 调节各种下游效应因子,包括转录因子、营养传感器、糖原合成、线粒体功能、昼夜节律和细胞命运。GSK-3 还调节响应 T 细胞受体激活的选择性剪接,最近的磷酸化蛋白质组学研究表明,多种剪接因子和 RNA 生物合成调节因子以 GSK-3 依赖的方式进行磷酸化。
GSK-3 的功能障碍或异常活动会导致多种疾病,如阿尔茨海默病 (AD) 和其他神经退行性疾病,以及其他类型的疾病,如糖尿病、心血管疾病和癌症。GSK-3 还与针对病原体的先天免疫反应有关,这使得 GSK-3 成为治疗干预的绝佳靶点。
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase consisting of two isoforms, alpha and beta. It is a highly conserved negative regulator of receptor tyrosine kinase, cytokine, and Wnt signaling pathways. Stimulation of these pathways inhibits GSK-3 to modulate diverse downstream effectors that include transcription factors, nutrient sensors, glycogen synthesis, mitochondrial function, circadian rhythm, and cell fate. GSK-3 also regulates alternative splicing in response to T-cell receptor activation, and recent phosphoproteomic studies have revealed that multiple splicing factors and regulators of RNA biosynthesis are phosphorylated in a GSK-3-dependent manner.
The malfunction or aberrant activity of GSK-3 leads to several of disorders, such as Alzheimer's disease (AD) and other neurodegenerative pathologies, and other type of diseases as diabetes, cardiovascular disorders and cancer. GSK-3 is also related to innate immune response against pathogens, which makes GSK-3 an excellent target for therapeutic intervention.
PROTAC GSK-3β Degrader-1(compound 1)是一种靶向 GSK-3β 的 PROTAC 降解剂,IC50 为 833 nM,由 SB-216763(GSK-3β 抑制剂)、PEG 连接子和 CRBN(E3 连接酶配体)组成,可降低 Aβ25-35 肽和 CuSO4 诱导的神经毒性,并可用于研究阿尔茨海默病(粉色:GSK-3β 配体 (MS-Y17858);蓝色:Cereblon 配体 (MS-Q68284);黑色:连接子 (MS-X05734))。
PROTAC GSK3 degrader-1 是一种强效的、具有血脑屏障穿透性的 GSK3 PROTAC 降解剂,对 GSK3β 的 DC50 为 1.4 nM,对 GSK3α 和 GSK3β 均有同等强效降解作用,可抑制 CRMP2、PRKAA1 和 Tau 的磷酸化并稳定 β-连环蛋白,可用于阿尔茨海默病、帕金森病的研究(粉色:GSK-3 配体 (MS-Y10656);蓝色:Cereblon 配体 (MS-M55078);黑色:连接子)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号